5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors.


BACKGROUND For patients with surgically untreatable neuroendocrine tumors (NETs), the optimal therapeutic approach remains undefined. Somatostatin analogs and interferons have failed to control neoplastic growth, and chemotherapy has been only moderately more effective. The authors' previous study of the combination of 5-fluorouracil (FU), dacarbazine (DTIC… (More)


  • Presentations referencing similar topics